TAMOXIFEN-ASSOCIATED STEATOHEPATITIS - REPORT OF 3 CASES

被引：68
|
作者：
PINTO, HC [1 ]
BAPTISTA, A [1 ]
CAMILO, ME [1 ]
DECOSTA, EB [1 ]
VALENTE, A [1 ]
DEMOURA, MC [1 ]
机构：
[1] UNIV LISBON, HOSP SANTA MARIA, DEPT PATHOL, P-1669 LISBON, PORTUGAL
来源：
JOURNAL OF HEPATOLOGY | 1995年 / 23卷 / 01期
关键词：
BREAST CARCINOMA; STEATOHEPATITIS; TAMOXIFEN;
D O I：
10.1016/0168-8278(95)80316-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The authors describe three cases of tamoxifen-associated steatohepatitis, which resulted from a daily dosage of 20 mg used as the adjuvant treatment of breast carcinoma. Liver tests became normal after discontinuation of tamoxifen. (C) Journal of Hepatology.
引用
收藏
页码：95 / 97
页数：3
相关论文
共 50 条
  • [21] USE OF INTRACAVITY SALINE INSTILLATION AND TRANSVAGINAL ULTRASONOGRAPHY TO DETECT TAMOXIFEN-ASSOCIATED ENDOMETRIAL POLYPS
    BOURNE, TH
    LAWTON, F
    LEATHER, A
    GRANBERG, S
    CAMPBELL, S
    COLLINS, WP
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1994, 4 (01) : 73 - 75
  • [22] Tamoxifen-associated postmenopausal adenomyosis exhibits stromal fibrosis, glandular dilatation and epithelial metaplasias
    McCluggage, WG
    Desai, V
    Manek, S
    HISTOPATHOLOGY, 2000, 37 (04) : 340 - 346
  • [23] Tamoxifen-associated venous thrombosis and activated protein C resistance due to Factor V Leiden
    Weitz, IC
    Israel, VK
    Liebman, HA
    CANCER, 1997, 79 (10) : 2024 - 2027
  • [24] Alterations of the K-ras and p53 genes in Tamoxifen-associated endometrial carcinoma
    Fujiwara, Kazuko
    Enomoto, Takayuki
    Fujita, Masami
    Kanda, Takayoshi
    Fujii, Shingo
    Ito, Kimihiko
    Wakasa, Kenichi
    Ishiko, Osamu
    Ueda, Masatsugu
    Yamaguchi, Satoshi
    Kimura, Tadashi
    Umesaki, Naohiko
    ONCOLOGY REPORTS, 2008, 19 (05) : 1293 - 1298
  • [25] Luteolin mitigates tamoxifen-associated fatty liver and cognitive impairment in rats by modulating beta-catenin
    El-Asfar, Rana K.
    El-Derany, Marwa O.
    Sallam, Al-Aliaa M.
    Wahdan, Sara A.
    El-Demerdash, Ebtehal
    Sayed, Sayed A.
    El-Mesallamy, Hala O.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 908
  • [26] Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma
    Ferguson, SE
    Olshen, AB
    Viale, A
    Awtrey, CS
    Barakat, RR
    Boyd, J
    GYNECOLOGIC ONCOLOGY, 2004, 92 (02) : 719 - 725
  • [27] Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature
    Leung, F.
    Terzibachian, J. J.
    Govyadovskiy, A.
    Bourtembourg, A.
    Aouar, Z.
    Fat, B. C.
    Maillet, R.
    Riethmuller, D.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2009, 38 (02): : 173 - 178
  • [28] Expression of Bcl-2 and Ki-67 in tamoxifen-associated endometrial polyps: Comparison with postmenopausal polyps
    Altaner, Semsi
    Gucer, Fatih
    Tokatli, Fusun
    Guresci, Servet
    Ozdemir, Cigdem
    Puyan, Fulya Oz
    Kutlu, Kemal
    ONKOLOGIE, 2006, 29 (8-9): : 376 - 380
  • [29] The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer
    Yan, Meiying
    Wang, Jingxuan
    Xuan, Qijia
    Dong, Tieying
    He, Juan
    Zhang, Qingyuan
    CLINICAL BREAST CANCER, 2017, 17 (03) : 195 - 203
  • [30] Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome
    Kirmizibekmez, Heves
    Mutlu, Rahime Gul Yesiltepe
    Dursun, Fatma
    Isguven, Sukriye Pinar
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2015, 28 (9-10) : 1191 - 1193
12345